Item does not contain fulltextThe prognosis of Henoch-Schonlein purpura (HSP) is mainly determined by the involvement of the kidney, but prognostic markers have not been established. To study the extent of tubular involvement in HSP and its relationship to the development of HSP nephritis, we measured the urinary excretion of two tubular marker proteins in 36 children with HSP. After admission, urinary N-acetyl-beta-D-glucosaminidase (NAG) was determined in 20 children and alpha1-microglobulin (alpha1-MG) in 16 children respectively. These values were compared with the biochemical data on admission, 1 month, 6 months, and 12 months later. A total of 198 24-h urine samples from healthy children were used for the establishment of reference da...
39th Annual Meeting of the European-Society-for-Paediatric-Nephrology -- SEP 10-13, 2005 -- Istanbul...
PubMed ID: 19439991Background/Aim: The aim of this retrospective study was to evaluate the presentat...
BACKGROUND AND AIM: The majority of patients (85-95%) with Henoch- Schonlein purpura nephritis (HSPN...
The prognosis of Henoch-Schonlein purpura (HSP) is mainly determined by the involvement of the kidne...
© 2017, University of Kragujevac, Faculty of Science. All rights reserved. Henoch-Schonlein purpura ...
Background: Matrix metalloproteinase-9 (MMP-9) is an enzyme implicated in the pathogenesis of renal ...
Background/Aim: The aim of this retrospective study was to evaluate the presentation, clinical and p...
Background/Aim: The aim of this retrospective study was to evaluate the presentation, clinical and p...
Chemokine monocyte chemoattractant protein-1 (MCP-1) has been proved as a potential urinary biomarke...
Purpose To compare clinical, pathological, and long-term renal outcomes of children with Henoch-Scho...
Purpose To compare clinical, pathological, and long-term renal outcomes of children with Henoch-Scho...
The aim of the study was to evaluate the usefulness of urinary collagen IV (Col IV) excretion for pr...
OBJECTIVE: To identify predictive factors for nephritis, relapse, and significant proteinuria in chi...
WOS: 000242513200012PubMed ID: 17024391Henoch-Schonlein purpura (HSP) is the most common vasculitis ...
Henoch-Schönlein purpura (HSP) is a systemic disorder characterized by leukocytoclastic vasculitis i...
39th Annual Meeting of the European-Society-for-Paediatric-Nephrology -- SEP 10-13, 2005 -- Istanbul...
PubMed ID: 19439991Background/Aim: The aim of this retrospective study was to evaluate the presentat...
BACKGROUND AND AIM: The majority of patients (85-95%) with Henoch- Schonlein purpura nephritis (HSPN...
The prognosis of Henoch-Schonlein purpura (HSP) is mainly determined by the involvement of the kidne...
© 2017, University of Kragujevac, Faculty of Science. All rights reserved. Henoch-Schonlein purpura ...
Background: Matrix metalloproteinase-9 (MMP-9) is an enzyme implicated in the pathogenesis of renal ...
Background/Aim: The aim of this retrospective study was to evaluate the presentation, clinical and p...
Background/Aim: The aim of this retrospective study was to evaluate the presentation, clinical and p...
Chemokine monocyte chemoattractant protein-1 (MCP-1) has been proved as a potential urinary biomarke...
Purpose To compare clinical, pathological, and long-term renal outcomes of children with Henoch-Scho...
Purpose To compare clinical, pathological, and long-term renal outcomes of children with Henoch-Scho...
The aim of the study was to evaluate the usefulness of urinary collagen IV (Col IV) excretion for pr...
OBJECTIVE: To identify predictive factors for nephritis, relapse, and significant proteinuria in chi...
WOS: 000242513200012PubMed ID: 17024391Henoch-Schonlein purpura (HSP) is the most common vasculitis ...
Henoch-Schönlein purpura (HSP) is a systemic disorder characterized by leukocytoclastic vasculitis i...
39th Annual Meeting of the European-Society-for-Paediatric-Nephrology -- SEP 10-13, 2005 -- Istanbul...
PubMed ID: 19439991Background/Aim: The aim of this retrospective study was to evaluate the presentat...
BACKGROUND AND AIM: The majority of patients (85-95%) with Henoch- Schonlein purpura nephritis (HSPN...